Micron’s $12.20 Earnings Blowout Sparks Sell-Off as Market Prices in Supply Crunch Limits and $25B Capex Reality

The numbers were spectacular. Micron's fiscal second-quarter earnings of $12.20 per share crushed the LSEG consensus estimate of $9.31, representing a 31% beat. Revenue of $23.86 billion also sailed past expectations, topping the $20.07 billion forecast. This wasn't a modest outperformance; it was a blowout, with revenue nearly tripling year-over-year.

Yet the market's reaction was the opposite of celebratory. Despite the stellar print, Micron stock fell more than 4% in early Thursday trading. This is the textbook definition of a "sell the news" event. The magnitude of the beat suggests the market had already priced in near-perfect results, leaving little room for positive surprise and highlighting concerns about sustainability.

The expectation gap was wide. The company's guidance for the current quarter only widened it further. Micron is projecting Q3 revenue of about $33.5 billion, which is well above the Zacks Consensus Estimate of $22.79 billion. This forward view implies the torrid growth isn't a one-quarter fluke. But even that strong outlook couldn't prevent the post-earnings sell-off, underscoring that the stock's massive run-up-up over 340% in the past year-had already baked in a best-case scenario. The reality, for now, was that the news was simply too good to be a surprise.

The Supply Crunch: A Double-Edged Sword for Expectations

The engine behind Micron's blowout earnings is clear: an extreme supply crunch. CEO Sanjay Mehrotra stated the company can only supply key customers about 50% to two-thirds of their requirements. This isn't just tightness; it's a fundamental bottleneck that has directly fueled the financial surge. The result is record pricing power, with sequential DRAM pricing increases of 65%-67% and a company-record gross margin of 75%. In this setup, Micron is the invisible layer powering AI, and the market is paying a premium for every chip it can get.

Yet the market's reaction to this supply-driven boom is a classic case of expectation arbitrage. The stock fell after the earnings, not because the news was bad, but because the reality of the supply constraint introduces a near-term constraint that the market is now pricing in. The primary concern is sustainability. The current high-margin environment is a direct function of scarcity, not a new permanent advantage. Investors are looking ahead to the inevitable expansion of capacity, which will eventually ease the crunch and compress prices.

This is why the focus has shifted to capital expenditures. The company's guidance for fiscal 2026 spending to exceed $25 billion is a massive step up. While necessary to meet future demand, this surge in investment raises immediate questions about near-term cash flow and margin pressure. The market is weighing the current windfall against the cost of future growth. The setup is a double-edged sword: the supply crunch creates a durable earnings advantage in the short term, but it also signals that the company must spend heavily to maintain its position, creating a new source of uncertainty. For now, the market is betting that the supply constraint's benefits are already priced in, and the capex bill is the new reality.

The Dividend Signal and Valuation Reset

Management's confidence signal is clear. The company's free cash flow of $6.9 billion was a quarterly record, and it used that strength to announce a 30% increase in its quarterly dividend. This move is a direct vote of confidence in the durability of its long-term profitability. It tells investors that the current boom is not just a cyclical spike but a fundamental shift in the business's earning power, supported by the AI-driven demand and pricing power.

Yet the market's reaction to this confidence signal is telling. Even as the dividend hike was announced, the stock fell. This is the expectation gap in action. The valuation now reflects a stark contrast. While the company's financials are soaring, its stock trades at a price-to-earnings multiple of 6 times William Blair's 2026 estimate, which is below its historical multiple. Some analysts see this as a buying opportunity, arguing the stock has room for upside. But the broader market is looking past the current cheapness to the future cost of sustaining it.

The critical watchpoint is the capital expenditure bill. The company's guidance for fiscal 2026 spending to exceed $25 billion is a massive step up. This investment is necessary to meet demand, including the Idaho site expected by mid-2027. But it also resets the expectation gap. The market is now pricing in that this spending will eventually pressure margins and cash flow, even as it benefits from the current supply crunch. The dividend increase signals confidence in the long-term profit engine, but the capex surge reminds everyone that the path to that future is expensive. For now, the market is betting that the current valuation discount is a temporary mispricing, not a permanent reset.